Increased Soluble VCAM-1 and Normal P-Selectin in Cystic Fibrosis: a Cross-Sectional Study

Jan K Nowak1, Irena Wojsyk-Banaszak2, Edyta Mądry3

  • 1Department of Pediatric Gastroenterology and Metabolic Diseases, Poznan University of Medical Sciences, Poznan, Poland.

Lung
|June 25, 2017
PubMed

Insights

Cystic fibrosis (CF) patients have higher levels of soluble vascular cell adhesion molecule 1 (sVCAM-1) compared to healthy individuals. These elevated sVCAM-1 levels in CF are not explained by common CF characteristics, suggesting a potential link to cardiovascular health.

Area of Science:

  • Cardiovascular Health
  • Pulmonary Medicine
  • Biomarker Discovery

Background:

  • Increasing life expectancy in cystic fibrosis (CF) necessitates understanding its long-term impacts, including cardiovascular health.
  • Soluble vascular cell adhesion molecule 1 (sVCAM-1) and P-selectin (sP-selectin) are investigated as potential biomarkers for cardiovascular disease.
  • The study addresses the emerging questions about cardiovascular implications in the growing CF population.

Purpose of the Study:

  • To compare serum concentrations of sVCAM-1 and sP-selectin in clinically stable CF patients versus healthy subjects (HS).
  • To determine if sVCAM-1 and sP-selectin levels independently correlate with specific CF characteristics.
  • To investigate potential cardiovascular disease biomarkers in the context of CF.

Main Methods:

  • Serum sVCAM-1 and sP-selectin levels were quantified using enzyme-linked immunosorbent assay (ELISA).
  • CF patient characteristics included lung function (FEV1), pancreatic and liver disease status, Pseudomonas aeruginosa colonization, hsCRP, and BMI.
  • CFTR genotypes were categorized as severe (classes I/II) or other.

Main Results:

  • CF patients (n=108) exhibited significantly higher sVCAM-1 concentrations than HS (n=51) (p < 10⁻⁴).
  • No significant difference was observed in sP-selectin levels between CF patients and HS (p = 0.48).
  • Multivariable regression models could not validate the prediction of sVCAM-1 or sP-selectin based on CF characteristics.

Conclusions:

  • Elevated sVCAM-1 levels are present in CF patients compared to healthy individuals.
  • The observed increase in sVCAM-1 in CF is not attributable to known CF-related clinical parameters.
  • Further investigation is warranted to ascertain if sVCAM-1 serves as a marker for microangiopathy in cystic fibrosis.
Abstract

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
953
Selectins01:25

Selectins

Cell adhesion is  an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
4.6K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
588